Cargando...
FGF21 in Obesity and Cancer: New Insights
The endocrine FGF21 was discovered as a novel metabolic regulator in 2005 with new functions bifurcating from the canonic heparin-binding FGFs that directly promote cell proliferation and growth independent of a co-receptor. Early studies have demonstrated that FGF21 is a stress sensor in the liver...
Gardado en:
| Publicado en: | Cancer Lett |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779663/ https://ncbi.nlm.nih.gov/pubmed/33264641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2020.11.026 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|